$CTXR | Potential $500M Product Entering Phase 3 Trials
20 Jun
2016
Written by Mike Elliott

$CTXR | Potential $500M Product Entering Phase 3 Trials »

Citius is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for healthcare markets where there are unmet needs using innovative, patented or proprietary formulations of pharmaceutical products.

Read more...

Login

Lost your password?